Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

BUPIVACAINE HYDROCHLORIDE INJECTION

Awarded
SPE2DP26F8859Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Contract SPE2DP26F8859 is a firm-fixed-price delivery order issued by the Defense Logistics Agency under parent contract SPE2DX25D9900. Awarded on August 9, 2026, to DMS Pharmaceutical Group Inc (CAGE 1UNB0), the contract is for the procurement of one package of Bupivacaine Hydrochloride Injection (NSN 6505011277946) for a total price of $26.40. The pharmaceutical product, manufactured by Fresenius Kabi USA, LLC, is classified under NAICS code 325412. The delivery is scheduled for August 24, 2026, with a destination of Fort Bragg, NC. Terms are FOB Destination, meaning the contractor is responsible for all transportation costs, and both inspection and acceptance will occur at the delivery point. Due to the nature of the medical supply, the contractor must use the fastest traceable shipping means, and the use of parcel post is strictly prohibited. There is zero tolerance for quantity variance on this order.

General Info

DLA awarded DMS Pharmaceutical Group $26.40 for Bupivacaine Hydrochloride delivery to Fort Bragg.

Contract Value

$26.4

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

Contract Document SPE2DP26F8859 for Bupivacaine Hydrochloride Injection

PDF, High priority: read this firstcontract-document
High

SPE2DP26F8859.pdf Unreadable Document

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F8859 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $26.40 Award Date: 08-09-2026 Delivery order under: SPE2DX25D9900 Line items: - BUPIVACAINE HYDROCHLORIDE INJECTION (NSN/Part 6505011277946, PR 7017807511)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS